Concert Pharmaceuticals to Report Second Quarter 2018 Financial Results on August 2, 2018
26 July 2018 - 9:00PM
Business Wire
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced
that it will report its second quarter 2018 financial results on
Thursday, August 2, 2018, before the U.S. financial markets open.
The Company will host a conference call and webcast at 8:30 a.m. ET
to discuss second quarter financial results and provide a business
update. Individuals interested in participating in the call should
dial (855) 354-1855 (U.S. and Canada) or (484) 365-2865
(International).
A live webcast of the second quarter financial results may be
accessed in the Investors section of the Company’s website at
www.concertpharma.com. Please log on to the Concert website
approximately 15 minutes prior to the scheduled webcast to ensure
adequate time for any software downloads that may be required. A
replay of the second quarter financial results webcast will be
available on Concert’s website for three months.
About ConcertConcert Pharmaceuticals is a clinical stage
biopharmaceutical company focused on applying its DCE Platform®
(deuterated chemical entity platform) to create novel medicines
designed to treat serious diseases and address unmet patient needs.
The Company’s approach starts with previously studied compounds,
including approved drugs, in which deuterium substitution has the
potential to enhance clinical safety, tolerability or efficacy.
Concert has a broad pipeline of innovative medicines
targeting autoimmune and inflammatory diseases and central nervous
systems (CNS) disorders. For more information please visit
www.concertpharma.com or follow us on Twitter at @ConcertPharma or
on LinkedIn.
Concert Pharmaceuticals Inc., the CoNCERT
Pharmaceuticals Inc. logo and DCE Platform are registered
trademarks of Concert Pharmaceuticals, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180726005039/en/
Concert Pharmaceuticals, Inc.Justine Koenigsberg,
781-674-5284ir@concertpharma.com
Concert Pharmaceuticals (NASDAQ:CNCE)
Historical Stock Chart
From Apr 2024 to May 2024
Concert Pharmaceuticals (NASDAQ:CNCE)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Concert Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Concert Pharmaceuticals, Inc. News Articles